首页> 美国卫生研究院文献>other >Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy

【2h】

Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy

机译：接受挽救疗法的转移性肾细胞癌患者评估肿瘤反应的替代反应标准和临床危险因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveThe purpose of this study is to compare the prognostic value of various solid tumor response criteria as well as the additive value of clinical risk factors in patients with advanced renal cell carcinoma (RCC).

机译：目的本研究的目的是比较各种实体瘤反应标准对晚期肾细胞癌（RCC）患者的预后价值以及临床危险因素的附加价值。

著录项

期刊名称 other
作者
Hyunseon C. Kang; Shiva Gupta; Wei Wei; Lina Lu; Marc R. Matrana; Nizar M. Tannir; Haesun Choi;
展开▼
作者单位

展开▼
年(卷),期 -1(209),6
年度 -1
页码 1278–1284
总页数 17
原文格式 PDF
正文语种
中图分类
关键词
clinical risk factors pazopanib renal cell carcinoma salvage therapy tumor response criteria;

机译：临床危险因素;帕唑帕尼;肾细胞癌;挽救疗法;肿瘤反应标准;

相似文献

外文文献
中文文献
专利

1. Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy [J] . Kang Hyunseon C., Gupta Shiva, Wei Wei, AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2017,第6期

机译：用于评估正在接受拯救肾细胞癌患者肿瘤反应的替代响应标准和临床风险因素
2. Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography [J] . Manoj Gupta, Partha Sarathi Choudhury, Sudhir Rawal, Urology Annals . 2019,第2期

机译：用卢特测定液体放射治疗抗腐蚀前列腺癌患者的响应评价：实体瘤中响应评价标准的响应评价标准的比较，实体瘤中正面瘤，欧洲研究和治疗组织巨蟹座和MDA标准由镓68-前列腺特异性膜抗原正电子排放断层摄影层析成像分析
3. Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma [J] . Pierre I Karakiewicz, Louise Nott, Abhishek Joshi, OncoTargets and therapy . 2016,第3期

机译：根据先前在转移性肾细胞癌治疗患者中实体瘤反应评价标准与Choi标准对阿昔替尼的反应评价
4. Matrix Metalloproteinase-2 and High Vascular Endothelial Growth Factor as Prognostic Markers for Intrahepatic Tumor Recurrence in Hepatocellular Carcinoma Patients Receiving Radiotherapy [C] . Eun-Jung Lee, Jinsil Seong, Yang-Gun Suh, Molecular Medicine TRI-CON. . 2014

机译：基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物，接受放射治疗
5. Associating Computed Tomography (CT) Imaging Response Criteria and Texture Analysis Measurements with Survival in Patients with Metastatic Melanoma Treated with Anti-angiogenic Therapy. [D] . Gray, Mark Russell. 2014

机译：将计算机断层扫描（CT）成像反应标准和纹理分析测量值与接受抗血管生成治疗的转移性黑色素瘤患者的生存率相关联。
6. Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma [O] . Pierre I Karakiewicz, Louise Nott, Abhishek Joshi, 2016

机译：根据既往治疗的转移性肾细胞癌患者的实体瘤反应评价标准与Choi标准评价阿昔替尼的反应
7. Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy [O] . Hyunseon C. Kang, Shiva Gupta, Wei Wei, 2017

机译：替代响应标准和临床危险因素，用于评估患者肾细胞癌患者接受拯救疗法的肿瘤反应

Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy

摘要

著录项

相似文献

相关主题

期刊订阅